MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

csiro: polynovo cost benefit analysis, page-10

  1. 167 Posts.
    Once a dog always a dog...
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.